Skip to main content

Advertisement

Log in

Development of a psilocin immunoassay for serum and blood samples

  • Original Article
  • Published:
International Journal of Legal Medicine Aims and scope Submit manuscript

Abstract

After the immunisation of rabbits with a psilocin-specific immunogen, polyclonal antisera were obtained. With these antisera a competitive, heterogeneous radioimmunoassay for the detection of psilocin was developed. As tracer a derivative of psilocin was synthesised, which contained a tritiated CH3 group. The antisera showed a specific reaction with psilocin. The cross-reactivity of structurally related endogenous substances like serotonin, tryptophan and tyrosine was below 0.01%. Also common drugs of abuse (Δ9-tetrahydrocannabinol, cocaine, morphine, amphetamine) showed negligible cross-reactivity (0.01–2%). Only tricyclic neuroleptics with a (dimethylamino)ethyl side-chain showed some cross-reactivity (20%). Spiked serum and blood samples were analysed with this new immunoassay and the results obtained were compared with the values measured with a validated GC-MS method.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Passie T, Seifert J, Schneider U, Emrich HM (2002) The pharmacology of psilocybin. Addict Biol 7:357–364

    Article  CAS  PubMed  Google Scholar 

  2. Horita A, Weber LJ (1961) The enzymic dephosphorylation and oxidation of psilocybin and psilocin by mammalian tissue homogenates. Biochem Pharmacol 7:47–54

    Article  CAS  PubMed  Google Scholar 

  3. Horita A, Weber LJ (1962) Dephosphorylation of psilocybin in the intact mouse. Toxicol Appl Pharmacol 4:730–737

    CAS  PubMed  Google Scholar 

  4. Kalberer F, Kreis W, Rutschmann J (1962) The fate of psilocin in the rat. Biochem Pharmacol 11:261–269

    Article  CAS  PubMed  Google Scholar 

  5. Hasler F, Bourquin D, Brenneisen R, Baer T, Vollenweider FX (1997) Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man. Pharma Acta Helv 72:175–184

    Article  CAS  Google Scholar 

  6. Sticht G, Käferstein H (2000) Detection of psilocin in body fluids. Forensic Sci Int 113:403–407

    Article  CAS  PubMed  Google Scholar 

  7. Kysilka R (1990) Determination of psilocin in rat urine by high-performance liquid chromatography with electrochemical detection. J Chromatogr 534:287–290

    Article  CAS  PubMed  Google Scholar 

  8. Lindenblatt H, Kramer E, Holzmann-Erens P, Gouzoulis-Mayfrank E, Kovar K-A (1998) Quantitation of psilocin in human plasma by high-performance liquid chromatography and electrochemical detection: comparison of liquid-liquid extraction with automated online solid-phase extraction. J Chromatogr B Biomed Sci Appl 709:255–263

    Article  CAS  PubMed  Google Scholar 

  9. Grieshaber AF, Moore KA, Levine B (2001) The detection of psilocin in human urine. J Forensic Sci 46:627–630

    CAS  PubMed  Google Scholar 

  10. Bogusz MJ (2000) Liquid chromatography-mass spectrometry as a routine method in forensic sciences: a proof of maturity. J Chromatogr B Biomed Sci Appl 748:3–19

    Article  CAS  PubMed  Google Scholar 

  11. Kamata T, Nishikawa M, Katagi M, Tsuchihashi H (2003) Optimized glucuronide hydrolysis for the detection of psilocin in human urine samples. J Chromatogr B Analyt Technol Biomed Life Sci 792:421–427

    Google Scholar 

  12. Sagawa K, Kimura A, Saito Y (2003) Production and characterization of a monoclonal antibody for sweat-specific protein and its application for sweat identification. Int J Legal Med 117:90–95

    PubMed  Google Scholar 

  13. Pavlic M, Haidekker A, Grubwieser P (2002) Fatal accident caused by isoflurane abuse. Int J Legal Med 116:357–360

    CAS  PubMed  Google Scholar 

  14. Albers C, Lehr M, Beike J, Kohler H, Brinkmann B (2002) Synthesis of a psilocin hapten and a protein-hapten conjugate. J Pharm Pharmacol 54:1265–1270

    Article  CAS  PubMed  Google Scholar 

  15. Nichols DE, Frescas S (1999) Improvements to the synthesis of psilocybin and a facile method for preparing the O-acetal prodrug of psilocin. Synthesis 6:935–938

    Article  Google Scholar 

  16. Yamada F, Tamura M, Somei M (1998) A facile synthesis of psilocin from indole-3-carbaldehyde. Heterocycles 49:451–457

    CAS  Google Scholar 

  17. Abraham GE (1969) Solid phase radioimmunoassay of estradiol-17 beta. J Clin Endocrinol Metab 29:866–870

    CAS  PubMed  Google Scholar 

  18. Troxler F, Seemann F, Hofmann A (1959) Synthetic indole compounds. II. Psilocybin and psilocin modifications. Helv Chim Acta 42:2073–2103

    CAS  Google Scholar 

  19. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Medicine CfV (2001) Guidance for industry. Bioanalytical validation

Download references

Acknowledgement

The authors wish to thank Dr. W. Schneider and the staff from Dade Behring GmbH Marburg who were responsible for the animal experimental section.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. Beike.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Albers, C., Köhler, H., Lehr, M. et al. Development of a psilocin immunoassay for serum and blood samples. Int J Legal Med 118, 326–331 (2004). https://doi.org/10.1007/s00414-004-0469-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00414-004-0469-9

Keywords

Navigation